Aethlon Medical, Inc. (AEMD)

NASDAQ: AEMD · IEX Real-Time Price · USD
1.420
-0.020 (-1.39%)
At close: Apr 17, 2024, 4:00 PM
1.470
+0.050 (3.52%)
After-hours: Apr 17, 2024, 7:04 PM EDT
-1.39%
Market Cap 3.72M
Revenue (ttm) 574,245
Net Income (ttm) -12.25M
Shares Out 2.62M
EPS (ttm) -5.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,378
Open 1.430
Previous Close 1.440
Day's Range 1.350 - 1.489
52-Week Range 1.360 - 7.200
Beta 1.94
Analysts Strong Buy
Price Target 10.00 (+604.23%)
Earnings Date Feb 14, 2024

About AEMD

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California. [Read more]

Industry Medical Devices
Sector Healthcare
CEO James B. Frakes M.B.A.
Employees 15
Stock Exchange NASDAQ
Ticker Symbol AEMD
Full Company Profile

Financial Performance

In 2022, AEMD's revenue was $574,245, an increase of 95.21% compared to the previous year's $294,165. Losses were -$12.03 million, 15.5% more than in 2021.

Financial Statements

Analyst Forecast

According to one analyst, the rating for AEMD stock is "Strong Buy" and the 12-month stock price forecast is $10.0.

Price Target
$10.0
(604.23% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier® Blood Filtration System SAN DIEGO , Feb. 21, 2024 /PRNewswire/ -- Aethlon Medical...

2 months ago - PRNewsWire

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , Feb. 14, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat c...

2 months ago - PRNewsWire

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

SAN DIEGO , Feb. 7, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, to...

2 months ago - PRNewsWire

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat c...

5 months ago - PRNewsWire

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A.

SAN DIEGO , Nov. 13, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, t...

5 months ago - PRNewsWire

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

SAN DIEGO , Nov. 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral infections and fo...

5 months ago - PRNewsWire

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

SAN DIEGO , Oct. 10, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral infections and f...

6 months ago - PRNewsWire

Aethlon Announces Reverse Stock Split

SAN DIEGO , Oct. 4, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, to...

7 months ago - PRNewsWire

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

SAN DIEGO , Aug. 30, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, t...

8 months ago - PRNewsWire

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , Aug. 10, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat c...

8 months ago - PRNewsWire

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023

SAN DIEGO , Aug. 3, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, to...

9 months ago - PRNewsWire

Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant

Proof-of-Concept Studies to Support the Use of the Hemopurifier  in the Ex Vivo Organ Perfusion Circuit SAN DIEGO, July 24, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therape...

9 months ago - PRNewsWire

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

SAN DIEGO , July 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, to...

10 months ago - PRNewsWire

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Conference Call to be Held Today at 4:30pm ET SAN DIEGO , June 28, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat canc...

10 months ago - PRNewsWire

Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023

SAN DIEGO , June 22, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, t...

10 months ago - PRNewsWire

Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation

Research to Confirm the Hemopurifier's Ability to Remove Harmful Viruses and Exosomes From Harvested Organs SAN DIEGO , June 21, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical th...

10 months ago - PRNewsWire

Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest

SAN DIEGO , June 14, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectiou...

11 months ago - PRNewsWire

Aethlon Medical to Present at the 13th Annual LD Micro Invitational

SAN DIEGO , June 1, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious...

11 months ago - PRNewsWire

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

SAN DIEGO , May 22, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious...

11 months ago - PRNewsWire

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

SAN DIEGO , Feb. 13, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectiou...

1 year ago - PRNewsWire

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023

SAN DIEGO , Feb. 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that i...

1 year ago - PRNewsWire

Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

Presentation on Thursday, February 2nd, 2023 at 10:00 AM ET SAN DIEGO , Jan. 31, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and ...

1 year ago - PRNewsWire

Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

SAN DIEGO , Jan. 30, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today announced that i...

1 year ago - PRNewsWire

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

SAN DIEGO , Nov. 14, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectiou...

1 year ago - PRNewsWire

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

SAN DIEGO , Nov. 2, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that i...

1 year ago - PRNewsWire